Clorox beats by $0.09, reports revs in-line; reaffirms FY19 EPS guidance, revs guidance
- Reports Q2 (Dec) earnings of $1.40 per share, $0.09 better than the S&P Capital IQ Consensus of $1.31; revenues rose 4.0% year/year to $1.47 bln vs the $1.47 bln S&P Capital IQ Consensus.
- Co reaffirms guidance for FY19, sees EPS of $6.20-6.40 vs. $6.32 S&P Capital IQ Consensus; sees FY19 revs of +2-4% to ~$62.46-63.69 bln vs. $6.33 bln S&P Capital IQ Consensus.
No comments:
Post a Comment